Combination of two drugs already available on the NHS could give patients extra months of life, study finds
Combination of two drugs already available on the NHS could give patients extra months of life, study finds
Copy link
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank…
It is estimated that 1,250 people a year could benefit from the new drug
New laws will let hospitals create personalised treatments on-site, cutting delays and improving outcomes for critically ill…
An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial,…
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank…
Personalised immunotherapy can keep disease at bay for more than four years
